Katie Nava
Family · San Antonio, TXNPI 1285006742
Payments from drug & device makers
Across 475 payments — averaging $23.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- Novartis$1K
- Johnson & Johnson$1K
- Mallinckrodt Hospital Products Inc.$922
- UCB, Inc.$836
- E.r. Squibb & Sons, L.L.C.$629
- plus $4K from 25 others
What the payments were for
- Food & beverage$10,79498%
- Education$1792%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 112 | $2,087 |
| Novartis | 66 | $1,443 |
| Johnson & Johnson(3 entities) | 47 | $1,183 |
| Mallinckrodt Hospital Products Inc. | 31 | $922 |
| UCB, Inc. | 35 | $836 |
| E.r. Squibb & Sons, L.L.C. | 19 | $629 |
| Lilly USA, LLC | 24 | $548 |
| ANI Pharmaceuticals, Inc. | 13 | $518 |
| AstraZeneca | 16 | $359 |
| Aurinia Pharma U.S., Inc. | 13 | $318 |
| Pfizer | 20 | $315 |
| Radius Health, Inc. | 18 | $308 |
| GSK | 3 | $210 |
| Genentech USA, Inc. | 13 | $201 |
| AbbVie | 2 | $168 |
| Fresenius Kabi USA, LLC | 7 | $161 |
| Pacira Therapeutics, Inc. | 7 | $139 |
| Ferring Pharmaceuticals Inc. | 7 | $104 |
| Janssen Scientific Affairs, LLC | 1 | $100 |
| Actelion Pharmaceuticals US, Inc. | 2 | $74 |
| Teva Pharmaceuticals USA, Inc. | 4 | $61 |
| Boehringer Ingelheim | 3 | $61 |
| Invivyd Inc | 2 | $46 |
| Celltrion USA Inc. | 2 | $40 |
| Sandoz | 2 | $36 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Octapharma USA, Inc. | 1 | $20 |
| Organon | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Scilex Pharmaceuticals Inc. | 1 | $15 |
| Cumberland Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$275
- ACTHAR$235
- PURIFIED CORTROPHIN GEL$229
- ORENCIA$196
- SIMPONI ARIA$125
- KRYSTEXXA$125
- Tavneos$123
- COBENFY$121
- Cimzia$118
- BENLYSTA$100
How this compares
$10,973 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 19 | $138,528 |
| Humira PenAdalimumab | 17 | $131,419 |
| Orencia ClickjectAbatacept | 24 | $130,761 |
| Hydroxychloroquine Sulfate | 61 | $3,193 |
| MethotrexateMethotrexate Sodium | 151 | $2,652 |
| Leflunomide | 45 | $1,821 |
| Tramadol Hcl | 35 | $336 |
| Prednisone | 81 | $303 |
| Duloxetine Hcl | 13 | $186 |
| Alendronate Sodium | 31 | $186 |
| Allopurinol | 26 | $169 |
| Methotrexate SodiumMethotrexate Sodium/Pf | 15 | $165 |
| Meloxicam | 25 | $26 |
| Fluoxetine Hcl | 12 | $22 |
Paid to pharmacies, not to this prescriber.
Other family in San Antonio
- Anna CastroSan Antonio$184K
- Natalia FariasSan Antonio$124K
- Ayoade AvworoSan Antonio$111K
- Tina CoppleSan Antonio$97K
- Kim HinojosaSan Antonio$63K
- Kimberly GibergaSan Antonio$36K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.